The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Open accessAbstract
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, activation of pyruvate kinase can inhibit cancer cell proliferation and tumor growth in some settings (Anastasiou et al., 2012; Kung et al., 2012; Walsh et al., 2010), but because pyruvate kinase expression is dispensable for the growth of some tumors (Cortes-Cros et al., 2013; Israelsen et al., 2013), whether pyruvate kinase activation will lead to durable responses remains an area of”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Anastasiou et al., 2012
In the citing paper
“Activating PKM2 by using small-molecule agonists increases PEP-to-pyruvate conversion, reducing the flux of glycolytic intermediates toward anabolic pathways and slowing tumor cell growth (56, 60).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“PKM2 exists as either an inactive dimer or an active tetramer, and oscillation between these two states influences the ability of cells to maintain anabolic metabolism (56).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“In order to examine the functional relevance of PKM2 for LPS action we next examined the effect of two highly specific small-molecule PKM2 activators, TEPP-46 and DASA-58.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“TEPP-46, but not DASA-58, is pharmacokinetically validated in vivo (Anastasiou et al., 2012).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“These well-characterized and highly specific compounds bind PKM2, which then forms a tight tetramer with PKM1-like kinetic properties, an event that is resistant to inhibition by tyrosine phosphorylation.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationRefinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,837
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 830
Lemos, F. O., de Ridder, I., Wagner, L. E., Bootman, M. D., Bultynck, G., Yule, D. I., & Parys, J. B. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119796 · Cited by 5
Conceptualizing Eukaryotic Metabolic Sensing and Signaling
Laxman, S. (2017) · Journal of the Indian Institute of Science · doi:10.1007/s41745-016-0013-1 · Cited by 5
Uncovering New Challenges in Targeting Glycolysis to Treat Th17 Cell-Mediated Autoimmunity
Mosure, S. A., & Solt, L. A. (2021) · Immunometabolism · doi:10.20900/immunometab20210006 · Cited by 5
Zheng, T., Huang, L., Chen, N., Xue, H., Ni, P., & Huang, G. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2597 · Cited by 5
Farhana, A., Koh, A. E.-H., Tong, J., Alsrhani, A., Kumar, S. S., & Mok, P. L. (2021) · Molecules · doi:10.3390/molecules26175414 · Cited by 5
Aberrant splicing in human cancer: An RNA structural code point of view
Apostolidi, M., & Stamatopoulou, V. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1137154 · Cited by 5
Kaya, M. O., Demirci, T., Çalışır, Ü., Özdemir, O., Kaya, Y., & Arslan, M. (2023) · Research on Chemical Intermediates · doi:10.1007/s11164-023-05149-6 · Cited by 5
Pyruvate kinase M2 promotes hair regeneration by connecting metabolic and Wnt/β- catenin signalingPreprint
Ryu, Y. C., Kim, Y.-R., Park, J., Choi, S., Ryu, W., Kim, G.-U., Kim, E., Hwang, Y., Kim, H., Han, G., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1572253/v1 · Cited by 5
Ensink, E., Jordan, T., Medeiros, H. C. D., Thurston, G., Pardal, A., Yu, L., & Lunt, S. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.15.557984 · Cited by 5
Self-citationThe role and mechanism of aerobic glycolysis in nasopharyngeal carcinoma
Pan, Z., Liu, Y., Li, H. Y., Qiu, H., Zhang, P., Li, Z., Wang, X., Tian, Y., Feng, Z., Zhu, S., et al. (2025) · PeerJ · doi:10.7717/peerj.19213 · Cited by 5
Pan, W. W., Weh, K. M., Chaudhury, S., Fernando, R., Hager, H. M., Wen, B., Chinnaswamy, K., Stuckey, J. A., Rech, J. C., Besirli, C. G., et al. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.7.26 · Cited by 4
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation
Buck, M. D., Castro‐Dopico, T., Schulz, O., Cardoso, A., Chakravarty, P., Legrave, N. M., Henry, C. M., Canton, J., Wu, E., Lee, S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00620-z · Cited by 5
Catabolic rewiring in cancer impacts dietary interventions
Chinopoulos, C. (2025) · Communications Biology · doi:10.1038/s42003-025-09333-9 · Cited by 6
Kosakai, W., Inoue, T., Sato, T., & Okada, H. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111029 · Cited by 4
Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances
Zhang, J., Zhang, T., Song, D., & Xu, D. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189537 · Cited by 4
Subleski, J. J., Palmieri, E. M., Walls, J. F., Hsu, T. C., Bettencourt, I. A., Gower, T., Durum, S. K., & McVicar, D. W. (2026) · Science Advances · doi:10.1126/sciadv.aec5092 · Cited by 5
A proposition for a cancer treatment study using radioactive metal co-factor enzymes
Luyen, T. V. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i2.519 · Cited by 4
Singh, V. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06769-0 · Cited by 4
Li, H., Parker, D., Zhang, J., & Li, H. (2023) · Journal of Luminescence · doi:10.1016/j.jlumin.2023.119852 · Cited by 4
Yang, L., Hu, C., Chen, X., Zhang, J., Feng, Z., Xiao, Y., He, W., Cui, T., Zhang, X., Yang, Y., et al. (2024) · eLife · doi:10.7554/elife.98181 · Cited by 21
Fluorescent binding assay for allosteric ligands of liver pyruvate kinase
Nilsson, O., Bogucka, A., Köteles, I., Håversen, L., Liljenberg, S., Rutberg, M., Hyvönen, M., & Grøtli, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117989 · Cited by 4
Glucose Metabolism and Carcinogenesis: The Impact of the Tumor Suppressor p53
Ntwasa, M. M., & Njende, U. (2018) · InTech eBooks · doi:10.5772/intechopen.75976 · Cited by 5
Nandi, S., & Dey, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282508 · Cited by 3
ACLY alternative splicing correlates with cancer phenotypes
Supplee, J., Affronti, H. C., Duan, R., Brooks, R. C., Stine, Z. E., Nguyen, P. T., Pinheiro, L. V., Noji, M., Drummond, J. M., Huang, K. W., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107418 · Cited by 4
Baas, T. (2013) · Science-Business eXchange · doi:10.1038/scibx.2013.28 · Cited by 4
Jin, C., Hu, W. M., Wang, Y., Wu, H., Zeng, S., Ying, M., & Hu, X. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107648 · Cited by 4
Tamarit‐Rodriguez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072947 · Cited by 3
PKM2 Facilitates Classical Swine Fever Virus Replication by Enhancing NS5B Polymerase Function
Song, M., Liu, S., Yan, L., Ji, T., Zhang, Y., & Deng, W. (2025) · Viruses · doi:10.3390/v17050648 · Cited by 3
Chang, S., Feng, X., Chen, X., Pan, M., Jiang, X., Ke, Z., Yang, X., Guan, M., Zha, X., Zhang, L., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112066 · Cited by 3
PKM2 regulates angiogenic activation via ANGPT2 in endothelial cells
Qiangqiang, G., Guo, J., Ye, L., Le, Y., & Zhu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-17147-2 · Cited by 3
The CLIC1-PKM2 axis orchestrates glycolytic metabolism to accelerate gastric cancer progression
Yang, J., Yu, Z., Feng, Y., Wang, S., Li, C., Mao, Y., Xu, W., & Chen, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07463-6 · Cited by 3
A shift in PKM2 oligomeric state instructs adipocyte inflammatory potential
Damen, M. S. M. A., Alarcon, P. C., Chan, C. C., Stankiewicz, T. E., Chung, H., Sawada, K., Ulanowicz, C. J., Eom, J., Oates, J. R., Wayland, J. L., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.185914 · Cited by 3
Costantini, S., Romeo, I., Fanelli, G., Roca, M. S., Gualtieri, G., Bagnara, P., Polo, A., Gennaro, E. D., Ortuso, F., Alcaro, S., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07444-9 · Cited by 3
Jain, M., Sayyed, A. A., Gondaliya, P., Kapoor, S., Chatterjee, D. R., Das, R., Kalia, K., Khairnar, A., & Shard, A. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111673 · Cited by 3
Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2
Ng, S. K., Wood, J. P. M., Chidlow, G., Peet, D. J., & Casson, R. J. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.922217 · Cited by 3
p73 keeps metabolic control in the family
Fets, L., & Anastasiou, D. (2013) · Nature Cell Biology · doi:10.1038/ncb2810 · Cited by 3
Self-citationEnergy metabolism of T-lymphocytes and its biological significance
Yang, Y., Feng, J., Lü, S., & Wang, X. (2016) · 中国科学通报：英文版 · doi:10.1007/s11434-016-1138-3 · Cited by 3
Metabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
Meiliana, A., Dewi, N. M., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1598 · Cited by 3
Wu, W., & Wen, K. (2022) · Oncology Reports · doi:10.3892/or.2022.8365 · Cited by 3
The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1
Borde, C., Dillard, C., L’honoré, A., Quignon, F., Hamon, M., Marchand, C. H., Faccion, R. S., Costa, M. G. S., Pramil, É., Larsen, A. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147865 · Cited by 3
Modulation of DNA/RNA Methylation Signaling Mediating Metabolic Homeostasis in Cancer
Choubey, P., Kaur, H., & Bansal, K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_7 · Cited by 3
Vuong, N. B., Quang, H. V., Trang, B. N. L., Duong, D. H., Toàn, N. L., & Tong, H. V. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138677 · Cited by 3
Temizer, A. B., Uludoğan, G., Özçelik, R., Koulani, T., Özkırımlı, E., Ülgen, K. Ö., Karalı, N., & Özgür, A. (2024) · Molecular Informatics · doi:10.1002/minf.202300249 · Cited by 4
Zhong, Y., Li, G., Zhang, D., Xie, Y., Hao, L., Cai, Z., & Wang, X. (2024) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202400130 · Cited by 3
Pyruvate kinase M2 modulates Japanese encephalitis virus replication in neuronal cells
Bohara, V. S., Deshmukh, A., & Kumar, S. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002140 · Cited by 4
Une vision élargie des modèles explicatifs de la biologie des cancers
Bénard, J., & Larsen, C. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1752 · Cited by 3
Cerebral lactate metabolism and memory: Implications for Alzheimer's disease
Harris, R. A. (2017) · Scholarship@Western (Western University) · Cited by 3
ICBS2012 Catalyzes Robust Response from Global Chemical Biology Community
Johns, M. A. (2012) · ACS Chemical Biology · doi:10.1021/cb3007049 · Cited by 3
Chemoproteomics Maps Glycolytic Targetome in Cancer CellsPreprint
Hao, H., Tian, Y., Wan, N., Ding, M., Shao, C., Wang, N., Bao, Q., Lu, W., Hu, H., Sun, H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-129157/v1 · Cited by 3
Zhou, Z., Zheng, X., Zhao, J., Yuan, A., Shao, G.-C., Peng, B., Dong, M., Xu, Q., Xu, X., & Li, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.14.557850 · Cited by 3
Delobelle, Q., Inizan, T. J., Adjoua, O., Lagardère, L., Célerse, F., Maréchal, V., & Piquemal, J. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202402534 · Cited by 2
Altıntaş, R., Güngör, S., Aygün, E., Bakan, B., & Şişecioğlu, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146731 · Cited by 2
Zhang, H., Deng, Y., Lu, Y., Wang, M., Qiao, K., Yang, Z., Ning, S., & Liu, T. (2025) · Advanced Science · doi:10.1002/advs.202515097 · Cited by 2
Chen, T., Lo, C., Wu, M.-C., Sit, W. Y., Hsu, H., Huang, Y., Lu, C., Chen, Y., Fang, W., Yang, S. D., et al. (2025) · Advanced Science · doi:10.1002/advs.202519368 · Cited by 2
Wang, Y., Wang, Y., Zhang, W., Xu, Y., Narayan, N. S., Cheng, H., Yang, H., Huang, Y., Zhang, C. M., & Wang, C. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02549 · Cited by 2
Self-citationHernandez, L. F., Betancourt, L. R., Nakayasu, E. S., Ansong, C. K., Ceballos, G. A., Paredes, D., & Abdulreda, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168754 · Cited by 2
Ma, Y., Fang, F., Liao, K., Zhang, J., Chen, W., Liao, Y., Zhao, B., Fang, Y., Chen, Y., Wang, D., et al. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1886 · Cited by 3
Zhang, X., Zhang, L., Gao, Y., Liu, Z., & Gong, K. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03989-7 · Cited by 2
Synthesis and evaluation of isoxazole derivatives of lapachol as inhibitors of pyruvate kinase M2
Mali, D., Wadhwani, B. D., Nunia, V., Joshi, K., Nair, R., Kumar, T., & Khandelwal, P. (2024) · Synthetic Communications · doi:10.1080/00397911.2024.2383952 · Cited by 2
Parameswaran, P., Contractor, D., Kalmegh, V., Chaudhary, B., Kapoor, S., Sharma, S., Jain, A. K., & Shard, A. (2024) · ChemistrySelect · doi:10.1002/slct.202402522 · Cited by 2
Pyruvate Kinase PKM2: Basic and Translational Aspects in Molecular Diagnosis of Human Malignancies
Belousov, P. V. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297923601582 · Cited by 2
Cancer Metabolism: A Nexus of Matter, Energy, and Reactive Oxygen Species
Bingham, P. M., Stuart, S. D., & Zachar, Z. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_2 · Cited by 2
Virtual high-throughput screens identifying hPK-M2 inhibitors: Exploration of model extrapolation
Chen, J. J. F., Schmucker, L. N., & Visco, D. P. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.12.006 · Cited by 2
Designing innovative therapies for neuropathic pain: pros and cons of target‐based drug discovery
Inglese, J. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12079_3 · Cited by 2
Self-citationPhosphorylated PKM2 regulates endothelium-dependent vasodilation in diabetes.
Lu, B., Tang, L., Li, L., Zhou, X., Leng, Y., & Quan, C. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.220541 · Cited by 2
Role of Autophagy in Cancer Metabolism
Cheong, H. (2016) · InTech eBooks · doi:10.5772/64025 · Cited by 2
Linking TPPII to the protein interaction and signalling networks
Nahálková, J. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107291 · Cited by 2
Characterization of Protein-Metabolite and Protein-Substrate Interactions of Disease Genes
McFedries, A. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Macpherson, J. A., Theisen, A., Masino, L., Fets, L., Driscoll, P. C., Encheva, V., Snijders, A. P., Martin, S. R., Kleinjung, J., Barran, P. E., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/378133 · Cited by 2
Self-citationKim, M., Zhang, Y., & Birchmeier, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.22.424062 · Cited by 2
Nuclear PKM2 Promotes Pre-mRNA Processing by Binding G-QuadruplexesPreprint
Anastasakis, D. G., Apostolidi, M., Rinehart, J., & Hafner, M. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3942850 · Cited by 2
Patel, R., Kumar, A., Lokhande, K. B., Swamy, K. V., Sarode, S. C., & Sharma, N. K. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13668728 · Cited by 2
Michels, P. A. M., & Fothergill‐Gilmore, L. A. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0000621.pub3 · Cited by 2
Parola, M. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3561 · Cited by 1
Role in post-translational modification of M2-type pyruvate kinase in tumorigenesis and development.
Pan, T. S., Hao, J., Wang, Y., Duan, W., Yue, L., & Gao, X. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.230177 · Cited by 2
Kocemba‐Pilarczyk, K. A., Ostrowska, B., Trojan, S., & Dudzik, P. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00768-9 · Cited by 2
Promising Role of PKM2 in the Diagnosis and Prognosis of Ovarian Cancer
Borra, P. K., Chandra, P., Sharma, H., Fatima, S., Koneru, A., Athilli, L., Fatima, F., Kumar, N. B., & Sachan, N. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206394408250806065235 · Cited by 1
Chowdhury, M. G., Sahu, A. K., Rawat, V., Kapoor, S., Chatterjee, D. R., Ambast, P. K., & Shard, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144795 · Cited by 1
Guo, M., Li, X., Zhang, J., Yan, S., Zhang, S., Wen, Y., Zou, X., Wang, D., Yang, R., Shuan, W., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119451 · Cited by 1
Japanese encephalitis virus infection induces PKM2-dependent glycolysis to promote viral replication
Dong, S., Yu, J., Guo, Z., Zhang, X., Hu, R., Xie, H., Wu, H., & Chen, Z. (2025) · Animal Diseases · doi:10.1186/s44149-025-00199-2 · Cited by 1
Conformational Dynamics of PKM2 Regulate Hypoxia-Induced Pathological Retinal Angiogenesis
Zhu, P., Chang, H., Yang, Q., Chen, W., & Chang, Q. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.15.23 · Cited by 1
Ma, T. Y., Kuo, C., & Liu, P.-C. (2025) · Animals · doi:10.3390/ani15243634 · Cited by 1
The biology of PKM2 in the metabolism and senescence in diabetic kidney disease
Kayes, M. I., & Kanasaki, K. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70231 · Cited by 1
Jin, E., Foster, H. R., Potapenko, E. S., Huang, S. M., Dong, X., Hughes, J. W., & MERRINS, M. J. (2026) · Diabetes · doi:10.2337/db25-0510 · Cited by 1
Pyruvate kinase M2 in Alzheimer’s disease: from dysregulation to therapeutic inhibition
Gojani, E. G., Sutherland, R. J., & Mohajerani, M. H. (2026) · Brain Communications · doi:10.1093/braincomms/fcag054 · Cited by 1
Yang, M. N., Chen, Y., & Chang, M. X. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111237 · Cited by 1
Wang, Y., Zhang, W., Liu, Y., & Tang, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151944 · Cited by 1
Han, L., Gan, L., Schäfer, B., Voss, D. M., Danielsen, M. B., Kostov, O., Liu, J., Wang, T., Caruthers, M. H., Chen, H., et al. (2026) · Cell Discovery · doi:10.1038/s41421-026-00882-9 · Cited by 1
Mir, R., Barnawi, J., Algehainy, N. A., Jalal, M. M., Altayar, M. A., Almotairi, R., Tayeb, F. J., Moawadh, M. S., Bedaiwi, R. I., Almasoudi, K. S., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1897564 · Cited by 1
“Trojan” Methionine Probe Reveals PKM2 as a Methionine-Sensing Protein in the mTORC1 Pathway
Sang, Z., Zheng, Y., Wang, X., Wu, C., Zhao, J., Wang, J. J., Sui, S., & Wang, J. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c06772 · Cited by 1
Liu, X., Li, B., Dou, X., Ju, W., Liu, W., Zhang, F., Jin, C., Lu, Y., Wang, R., Chen, X., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104366 · Cited by 1
Chen, K., Chen, K., Chen, H., & Chen, C. Y. (2014) · BioMed Research International · doi:10.1155/2014/189495 · Cited by 1
Clarke, R. B., Stingl, J., Vivanco, M. D., & Bentires‐Alj, M. (2013) · Breast Cancer Research · doi:10.1186/bcr3497 · Cited by 1
What Can Study of Oligomerization of Proteins in the Process of Oncogenesis Bring Us?
Coufalová, D., Vojtěšek, B., & Hernychová, L. (2015) · Klinicka onkologie · doi:10.14735/amko20152s6 · Cited by 1
Origins of cancer symposium 2016: exploring tumor complexity
Harlow, M. L., Lee, K., & Winn, M. E. (2016) · Genes & Cancer · doi:10.18632/genesandcancer.119 · Cited by 1
Mitochondrial Energy Metabolism in Carcinogenesis
Kurhaluk, N., & Tkaczenko, H. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_226 · Cited by 1
PKM2 is a key regulator of cardiac lipid metabolism in mice
Lee, K. C. Y., Williams, A. L., Fujimoto, A., Gerschenson, M., Schuller, C., Polgár, N., Alfulaij, N., Shimada, B. K., Seale, L. A., & Shohet, R. V. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102070 · Cited by 1
Small-Molecule Reprogramming of Cancer Metabolism
Pratt, M. R. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.001 · Cited by 1
Modèles d’oncogenèse : un monde sans fin ?
Larsen, C. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1759 · Cited by 1
Qian, Y. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Metadata
- Authors
- Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., Yang, H., Mattaini, K. R., Metallo, C. M., Fiske, B. P., Courtney, K. D., Malstrom, S., Khan, T. M., Kung, C., Skoumbourdis, A. P., Veith, H., Southall, N., Walsh, M. J., Brimacombe, K. R., Leister, W., Lunt, S. Y., Johnson, Z. R., Yen, K. E., Kunii, K., Davidson, S. M., Christofk, H. R., Austin, C. P., Inglese, J., Harris, M. H., Asara, J. M., Stephanopoulos, G., Salituro, F. G., Jin, S., Dang, L., Auld, D. S., Park, H.-W., Cantley, L. C., Thomas, C. J., & Vander Heiden, M. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Massachusetts Institute of Technology (US)
- National Institutes of Health (US)
- University of Toronto (CA)
- Agios Pharmaceuticals (United States) (US)
- University of California San Diego (US)
- Boston Children's Hospital (US)
- ORCID
- Anastasiou, Dimitrios
- Yu, Yimin
- Israelsen, William J
- Jiang, Jian-Kang
- Tempel, Wolfram
- Shen, Min
- Jha, Abhishek
- Yang, Hua
- Mattaini, Katherine R
- Metallo, Christian M
- Fiske, Brian P
- Courtney, Kevin D
- Khan, Tahsin M
- Southall, Noel
- Walsh, Martin J
- Brimacombe, Kyle R
- Lunt, Sophia Y
- Johnson, Zachary R
- Yen, Katharine E
- Kunii, Kaiko
- Davidson, Shawn M
- Christofk, Heather R
- Austin, Christopher P
- Inglese, James
- Harris, Marian H
- Asara, John M
- Stephanopoulos, Gregory
- Salituro, Francesco G
- Dang, Lenny
- Auld, Douglas S
- Park, Hee-Won
- Cantley, Lewis C
- Thomas, Craig J
- Venue
- Nature Chemical Biology
- Published
- 2012-08-26
- Volume
- 8
- Issue
- 10
- Pages
- 839-847
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC3711671
- OpenAlex
- W2125836344
- Cited by
- 816
- References
- 46
- Citations by year
- 2026: 39 · 2025: 76 · 2024: 61 · 2023: 66 · 2022: 59 · 2021: 73 · 2020: 69 · 2019: 47 · 2018: 60 · 2017: 49 · 2016: 53 · 2015: 55 · 2014: 55 · 2013: 45 · 2012: 9
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-11-26)
- Open access
- green
- europepmc.org
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- University of Chicago
- Genome Canada
- Wellcome Trust
- Knut och Alice Wallenbergs Stiftelse
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Mental Health (R03MH085679)
- National Cancer Institute (5P30CA1405141, R01CA160458, P01CA120964, P30CA006516)
- National Institute of General Medical Sciences (R01 GM56203, R01GM056203)
- Biological and Environmental Research
- Argonne National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- PKM2, tetramerization, fructose-1,6-bisphosphate, small molecule activators, PKM1, tumor growth inhibition, tumor xenografts, cancer metabolism, glucose metabolism, tyrosine phosphorylation, anabolic metabolism, enzyme activation
- MeSH terms
- Animals, Biopolymers, Cell Transformation, Neoplastic, Humans, Neoplasms, Pyruvate Kinase, Blotting, Western, Enzyme Activators, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
